https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Quality of acute care and long-term quality of life and survival: the Australian Stroke Clinical Registry https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34583 Wed 23 Feb 2022 16:04:47 AEDT ]]> Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: an MSBase registry substudy https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39516 Wed 10 Aug 2022 11:31:35 AEST ]]> Prediction of multiple sclerosis outcomes when switching to ocrelizumab https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46515 Thu 24 Nov 2022 15:50:23 AEDT ]]> Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52624 Thu 19 Oct 2023 14:15:33 AEDT ]]> Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36736 Thu 02 Jul 2020 16:31:45 AEST ]]> Prediction of relapse activity when switching to cladribine for multiple sclerosis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51076 Fri 18 Aug 2023 09:03:23 AEST ]]>